vs

Side-by-side financial comparison of Legacy Education Inc. (LGCY) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $19.2M, roughly 1.9× Legacy Education Inc.). On growth, Legacy Education Inc. posted the faster year-over-year revenue change (40.7% vs -57.1%).

Legacy Education Inc. is a professional educational service provider focused on financial literacy, real estate investment, entrepreneurship, and personal wealth management training programs. It mainly serves individual learners across North America, Europe and select Asia-Pacific markets, offering both in-person workshops and online digital courses to help users build practical financial and business skills.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

LGCY vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.9× larger
ORGO
$37.2M
$19.2M
LGCY
Growing faster (revenue YoY)
LGCY
LGCY
+97.8% gap
LGCY
40.7%
-57.1%
ORGO

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
LGCY
LGCY
ORGO
ORGO
Revenue
$19.2M
$37.2M
Net Profit
$2.0M
Gross Margin
30.8%
Operating Margin
13.3%
-185.1%
Net Margin
10.6%
Revenue YoY
40.7%
-57.1%
Net Profit YoY
46.0%
EPS (diluted)
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LGCY
LGCY
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$19.2M
$225.6M
Q3 25
$19.4M
$150.9M
Q2 25
$18.0M
$101.0M
Q1 25
$18.6M
$86.7M
Q4 24
$13.6M
$126.7M
Q3 24
$14.0M
$115.2M
Q2 24
$130.2M
Net Profit
LGCY
LGCY
ORGO
ORGO
Q1 26
Q4 25
$2.0M
$43.7M
Q3 25
$2.2M
$21.6M
Q2 25
$1.2M
$-9.4M
Q1 25
$2.8M
$-18.8M
Q4 24
$1.4M
$7.7M
Q3 24
$2.1M
$12.3M
Q2 24
$-17.0M
Gross Margin
LGCY
LGCY
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
LGCY
LGCY
ORGO
ORGO
Q1 26
-185.1%
Q4 25
13.3%
28.1%
Q3 25
13.9%
13.7%
Q2 25
11.1%
-12.5%
Q1 25
19.7%
-30.9%
Q4 24
12.2%
8.1%
Q3 24
19.1%
5.4%
Q2 24
-10.7%
Net Margin
LGCY
LGCY
ORGO
ORGO
Q1 26
Q4 25
10.6%
19.4%
Q3 25
11.3%
14.3%
Q2 25
6.8%
-9.3%
Q1 25
15.2%
-21.7%
Q4 24
10.3%
6.1%
Q3 24
14.9%
10.7%
Q2 24
-13.1%
EPS (diluted)
LGCY
LGCY
ORGO
ORGO
Q1 26
Q4 25
$0.15
$0.31
Q3 25
$0.16
$0.11
Q2 25
$0.07
$-0.10
Q1 25
$0.21
$-0.17
Q4 24
$0.10
$0.05
Q3 24
$0.21
$0.09
Q2 24
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LGCY
LGCY
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$21.1M
$91.4M
Total DebtLower is stronger
$660.3K
Stockholders' EquityBook value
$46.1M
Total Assets
$73.1M
$520.0M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LGCY
LGCY
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$21.1M
$93.7M
Q3 25
$20.6M
$63.7M
Q2 25
$20.3M
$73.1M
Q1 25
$17.3M
$110.0M
Q4 24
$16.9M
$135.6M
Q3 24
$21.5M
$94.3M
Q2 24
$89.9M
Total Debt
LGCY
LGCY
ORGO
ORGO
Q1 26
Q4 25
$660.3K
Q3 25
$776.9K
Q2 25
$1.4M
Q1 25
$1.0M
Q4 24
$1.1M
Q3 24
$758.2K
$62.3M
Q2 24
$63.8M
Stockholders' Equity
LGCY
LGCY
ORGO
ORGO
Q1 26
Q4 25
$46.1M
$300.1M
Q3 25
$43.7M
$255.1M
Q2 25
$41.0M
$233.2M
Q1 25
$39.3M
$242.9M
Q4 24
$36.4M
$262.9M
Q3 24
$32.6M
$278.5M
Q2 24
$263.5M
Total Assets
LGCY
LGCY
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$73.1M
$598.7M
Q3 25
$72.1M
$509.8M
Q2 25
$69.2M
$461.1M
Q1 25
$67.1M
$467.4M
Q4 24
$62.1M
$497.9M
Q3 24
$50.6M
$446.3M
Q2 24
$443.2M
Debt / Equity
LGCY
LGCY
ORGO
ORGO
Q1 26
Q4 25
0.01×
Q3 25
0.02×
Q2 25
0.03×
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.02×
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LGCY
LGCY
ORGO
ORGO
Operating Cash FlowLast quarter
$1.1M
Free Cash FlowOCF − Capex
$512.7K
FCF MarginFCF / Revenue
2.7%
Capex IntensityCapex / Revenue
2.8%
Cash ConversionOCF / Net Profit
0.52×
TTM Free Cash FlowTrailing 4 quarters
$4.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LGCY
LGCY
ORGO
ORGO
Q1 26
Q4 25
$1.1M
$39.4M
Q3 25
$1.1M
$3.1M
Q2 25
$3.0M
$-32.9M
Q1 25
$918.7K
$-19.9M
Q4 24
$659.0K
$10.9M
Q3 24
$3.2M
$8.7M
Q2 24
$4.7M
Free Cash Flow
LGCY
LGCY
ORGO
ORGO
Q1 26
Q4 25
$512.7K
$34.8M
Q3 25
$809.7K
$844.0K
Q2 25
$2.9M
$-36.5M
Q1 25
$596.6K
$-23.6M
Q4 24
$466.8K
$7.6M
Q3 24
$2.9M
$6.1M
Q2 24
$2.9M
FCF Margin
LGCY
LGCY
ORGO
ORGO
Q1 26
Q4 25
2.7%
15.4%
Q3 25
4.2%
0.6%
Q2 25
16.2%
-36.1%
Q1 25
3.2%
-27.2%
Q4 24
3.4%
6.0%
Q3 24
21.1%
5.3%
Q2 24
2.2%
Capex Intensity
LGCY
LGCY
ORGO
ORGO
Q1 26
Q4 25
2.8%
2.1%
Q3 25
1.3%
1.5%
Q2 25
0.5%
3.6%
Q1 25
1.7%
4.2%
Q4 24
1.4%
2.7%
Q3 24
1.7%
2.2%
Q2 24
1.4%
Cash Conversion
LGCY
LGCY
ORGO
ORGO
Q1 26
Q4 25
0.52×
0.90×
Q3 25
0.48×
0.14×
Q2 25
2.45×
Q1 25
0.33×
Q4 24
0.47×
1.43×
Q3 24
1.52×
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons